Skip to content

Clinical trials

Phase 3 Hyperlipidemias trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 3 Country / region: Netherlands Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20051
20071
20137
20142
20162
20211
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting3
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen6
Pfizer5
Novartis Pharmaceuticals4
Takeda2
AstraZeneca1
Bayer1
Esperion Therapeutics, Inc.1
Ionis Pharmaceuticals, Inc.1
NewAmsterdam Pharma1
Solvay Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias23
Hypercholesterolemia12
Dyslipidemias6
Cardiovascular Diseases5
Hyperlipoproteinemia Type II3
Myocardial Infarction3
Stroke3
Aortic Valve Stenosis2
Atherosclerosis2
Coronary Artery Disease2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.